These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 1442566)
1. Assessing viable myocardium with thallium-201. Bonow RO; Dilsizian V Am J Cardiol; 1992 Nov; 70(14):10E-17E. PubMed ID: 1442566 [TBL] [Abstract][Full Text] [Related]
2. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography. Dilsizian V; Perrone-Filardi P; Arrighi JA; Bacharach SL; Quyyumi AA; Freedman NM; Bonow RO Circulation; 1993 Sep; 88(3):941-52. PubMed ID: 8353921 [TBL] [Abstract][Full Text] [Related]
3. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. Bonow RO; Dilsizian V; Cuocolo A; Bacharach SL Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883 [TBL] [Abstract][Full Text] [Related]
4. Thallium 201 for assessment of myocardial viability. Bonow RO; Dilsizian V Semin Nucl Med; 1991 Jul; 21(3):230-41. PubMed ID: 1948113 [TBL] [Abstract][Full Text] [Related]
5. Differential uptake and apparent 201Tl washout after thallium reinjection. Options regarding early redistribution imaging before reinjection or late redistribution imaging after reinjection. Dilsizian V; Bonow RO Circulation; 1992 Mar; 85(3):1032-8. PubMed ID: 1537101 [TBL] [Abstract][Full Text] [Related]
6. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose. Dilsizian V; Arrighi JA; Diodati JG; Quyyumi AA; Alavi K; Bacharach SL; Marin-Neto JA; Katsiyiannis PT; Bonow RO Circulation; 1994 Feb; 89(2):578-87. PubMed ID: 8313546 [TBL] [Abstract][Full Text] [Related]
7. Regional left ventricular wall thickening. Relation to regional uptake of 18fluorodeoxyglucose and 201Tl in patients with chronic coronary artery disease and left ventricular dysfunction. Perrone-Filardi P; Bacharach SL; Dilsizian V; Maurea S; Frank JA; Bonow RO Circulation; 1992 Oct; 86(4):1125-37. PubMed ID: 1394920 [TBL] [Abstract][Full Text] [Related]
8. [Thallium scintigraphy for determining myocardial vitality. Evaluation of the "stunned and hibernating myocardium"]. Nienaber CA; Carnarius H Herz; 1994 Feb; 19(1):7-18. PubMed ID: 8150416 [TBL] [Abstract][Full Text] [Related]
9. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. Dilsizian V; Rocco TP; Freedman NM; Leon MB; Bonow RO N Engl J Med; 1990 Jul; 323(3):141-6. PubMed ID: 2362606 [TBL] [Abstract][Full Text] [Related]
10. Thallium reinjection after stress-redistribution imaging. Does 24-hour delayed imaging after reinjection enhance detection of viable myocardium? Dilsizian V; Smeltzer WR; Freedman NM; Dextras R; Bonow RO Circulation; 1991 Apr; 83(4):1247-55. PubMed ID: 2013145 [TBL] [Abstract][Full Text] [Related]
13. Comparison of rest-redistribution thallium-201 imaging and reinjection after stress-redistribution for the assessment of myocardial viability in patients with left ventricular dysfunction secondary to coronary artery disease. Galassi AR; Centamore G; Fiscella A; Coppola A; Liberti F; Franco M; Palazzo G; Musumeci S; Galassi A Am J Cardiol; 1995 Mar; 75(7):436-42. PubMed ID: 7863985 [TBL] [Abstract][Full Text] [Related]
15. Regional thallium uptake in irreversible defects. Magnitude of change in thallium activity after reinjection distinguishes viable from nonviable myocardium. Dilsizian V; Freedman NM; Bacharach SL; Perrone-Filardi P; Bonow RO Circulation; 1992 Feb; 85(2):627-34. PubMed ID: 1735157 [TBL] [Abstract][Full Text] [Related]
16. Thallium scintigraphy compared with 18F-fluorodeoxyglucose positron emission tomography for assessing myocardial viability in patients with moderate versus severe left ventricular dysfunction. Marin-Neto JA; Dilsizian V; Arrighi JA; Perrone-Filardi P; Bacharach SL; Bonow RO Am J Cardiol; 1998 Nov; 82(9):1001-7. PubMed ID: 9817471 [TBL] [Abstract][Full Text] [Related]
17. Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting. Ohtani H; Tamaki N; Yonekura Y; Mohiuddin IH; Hirata K; Ban T; Konishi J Am J Cardiol; 1990 Aug; 66(4):394-9. PubMed ID: 2386113 [TBL] [Abstract][Full Text] [Related]
18. Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. Vanoverschelde JL; D'Hondt AM; Marwick T; Gerber BL; De Kock M; Dion R; Wijns W; Melin JA J Am Coll Cardiol; 1996 Aug; 28(2):432-42. PubMed ID: 8800122 [TBL] [Abstract][Full Text] [Related]
19. Stress-induced reversible and mild-to-moderate irreversible thallium defects: are they equally accurate for predicting recovery of regional left ventricular function after revascularization? Kitsiou AN; Srinivasan G; Quyyumi AA; Summers RM; Bacharach SL; Dilsizian V Circulation; 1998 Aug; 98(6):501-8. PubMed ID: 9714106 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of tomographic rest-redistribution thallium 201 imaging in medically treated patients with coronary artery disease and left ventricular dysfunction. Gioia G; Milan E; Giubbini R; DePace N; Heo J; Iskandrian AS J Nucl Cardiol; 1996; 3(2):150-6. PubMed ID: 8799240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]